Application of NMR metabolomics to search for human disease biomarkers

Combinatorial Chemistry and High Throughput Screening

Volumn 15, Issue 8, 2012, Pages 595-610

  Gebregiworgis, Teklab ^a   Powers, Robert ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Biomarkers; Cmultivariate statistics; Metabolomics; NMR

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BILE; BLOOD; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID; CHEMOMETRIC ANALYSIS; DISEASE MARKER; EXPERIMENTATION; FECES; HUMAN; LUNG CANCER; LUNG LAVAGE; METABOLOMICS; PLASMA; PRIORITY JOURNAL; PROSTATE SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; PUS; SALIVA; SERUM; TISSUE WATER; URINE; VAGINAL SECRETION;

ANIMALS; BIOLOGICAL MARKERS; BODY FLUIDS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS;

EID: 84867250802     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/138620712802650522     Document Type: Article

References (134)

1. Freeman, B. C. Third-World Folk Beliefs and Practices: Haitian Medical Anthropology. La Presse Evangélique, Port-au-Prince, 2007.
2. Falagas, M. E. Science in Greece: from the age of Hippocrates to the age of the genome. FASEB J., 2006, 20 (12), 1946-1950.
3. White, W. I. A new look at the role of urinalysis in the history of diagnostic medicine. Clin. Chem., 1991, 37 (1), 119-125.
4. Nicholson, J.K.; Lindon, J. C. Metabonomics. Nature, 2008, 455 (23), 1045-1056.
5. Eknoyan, G.; Nagy, J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv. Chronic Kidney D., 2005, 12, (2), 223-229.
6. Durner, J. Clinical chemistry: Challenges for analytical chemistry and the nanosciences from medicine. Angew. Chem., Int. Ed., 2009, 49 (6), 1026-1051.
7. Robinson, B.; Pauling, L. Techniques of orthomolecular diagnosis. Clin. Chem., 1974, 20 (8), 961-965.
8. Messerli, G.; Partovi Nia, V.; Trevisan, M.; Kolbe, A.; Schauer, N.; Geigenberger, P.; Chen, J.; Davison, A. C.; Fernie, A. R.; Zeeman, S. C. Rapid classification of phenotypic mutants of arabidopsis via metabolite fingerprinting. Plant Physiol., 2007, 143 (4), 1484-1492.
9. Fiehn, O. Metabolomics - the link between genotypes and phenotypes. Plant Mol. Biol. 2002, 48 (1-2), 155-171.
10. Badano, J. L.; Katsanis, N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet., 2002, 3 (10), 779-789.
11. Rebbeck, T. R.; Domchek, S. M. Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res., 2008, 10 (108).
12. Mavaddat, N.; Antoniou, A. C.; Easton, D. F.; Garcia-Closas, M. Genetic susceptibility to breast cancer. Mol. Oncol., 2010, 4 (3), 174-191.
13. Nathanson, K. L.; Domchek, S. M. Therapeutic approaches for women predisposed to breast cancer. Annu. Rev. Med., 2011, 62, 295-306.
14. Howard, A. F.; Balneaves, L. G.; Bottorff, J. L.; Rodney, P. Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qual Health Res., 2011, 21 (4), 502-519.
15. Alberio, T.; Fasano, M. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies. J. Biotechnol., 2011, 156 (4), 325-337.
16. Denman, B.; Goodman, S. R. Emerging and neglected tropical diseases: translational application of proteomics. Exp. Biol. Med., 2011, 236 (8), 972-976.
17. Hanash, S. Progress in mining the human proteome for disease applications. OMICS, 2011, 15 (3), 133-139.
18. Wang, J.-Z.; Grundke-Iqbal, I.; Iqbal, K. Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease. Nature, 1996, 2 (8), 871-875.
19. Vucic, D.; Dixit, V. M.; Wertz, I. E. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol., 2011, 12 (7), 439-452.
20. Ehrnhoefer, D. E.; Sutton, L.; Hayden, M. R. Small changes, Big impact: posttranslational modifications and function of huntingtin in huntington disease. The Neuroscientist, 2011, 17 (5), 475-492.
21. Yamada, M.; Fujii, K.; Koyama, K.; Hirohashi, S.; Kondo, T. The proteomic profile of pancreatic cancer cell lines corresponding to carcinogenesis and metastasis. J. Proteomics Bioinf., 2009, 2 (1), 001-018.
22. Shen, J.; Person, M. D.; Zhu, J.; Abbruzzese, J. L.; Li, D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res., 2004, 64 (24), 9018-9026.
23. Chen, R.; Yi, E. C.; Donohoe, S.; Pan, S.; Eng, J.; Cooke, K.; Crispin, D. A.; Lane, Z.; Goodlett, D. R.; Bronner, M. P.; Aebersold, R.; Brentnall, T. A. Pancreatic cancer proteome: The proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology, 2005, 129 (4), 1187-1197.
24. Crnogorac-Jurcevic, T.; Gangeswaran, R.; Bhakta, V.; Capurso, G.; Lattimore, S.; Akada, M.; Sunamura, M.; Prime, W.; Campbell, F.; Brentnall, T. A.; Costello, E.; Neoptolemos, J.; Lemoine, N. R. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology, 2005, 129 (5), 1454-1463.
25. Grutzmann, R.; Boriss, H.; Ammerpohl, O.; Luttges, J.; Kalthoff, H.; Schackert, H. K.; Kloppel, G.; Saeger, H. D.; Pilarsky, C. Metaanalysis of microarray data on pancreatic cancer defines a set ofcommonly dysregulated genes. Oncogene, 2005, 24 (32), 5079-5088.
26. Biron, D. G.; Brun, C.; Lefevre, T.; Lebarbenchon, C.; Loxdale, H. D.; Chevenet, F.; Brizard, J.-P.; Thomas, F. The pitfalls of proteomics experiments without the correct use of bioinformatics tools. Proteomics, 2006, 6 (20), 5577-5596.
27. Reinders, J.; Lewandrowski, U.; Moebius, J.; Wagner, Y.; Sickmann, A. Challenges in mass spectrometry-based proteomics. Proteomics, 2004, 4 (12), 3686-3703.
28. Powers, R. NMR metabolomics and drug discovery. Magn. Reson. Chem., 2009, 47 (S1), S2-S11.
29. Zhang, G.-F.; Sadhukhan, S.; Tochtrop, G. P.; Brunengraber, H. Metabolomics, pathway regulation, and pathway discovery. J. Biol. Chem., 2011, 286, (27), 23631-23635.
30. Pauling, L.; Robinson, A. B.; Teranishit, R.; Cary, P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl. Acad. Sci. U S A, 1971, 68 (10), 2374-2376.
31. Dixon, R. A.; Gang, D. R.; Charlton, A. J.; Fiehn, O.; Kuiper, H. A.; Reynolds, T. L.; Tjeerdema, R. S.; Jeffery, E. H.; German, J. B.; Ridley, W. P.; Seiber, J. N. Applications of metabolomics in agriculture. J. Agric. Food Chem., 2006, 54 (24), 8984-8994.
32. Wang, T. J.; Larson, M. G.; Vasan, R. S.; Cheng, S.; Rhee, E. P.; McCabe, E.; Lewis, G. D.; Fox, C. S.; Jacques, P. F.; Fernandez, C.; O'Donnell, C. J.; Carr, S. A.; Mootha, V. K.; Florez, J. C.; Souza, A.; Melander, O.; Clish, C. B.; Gerszten, R. E. Metabolite profiles and the risk of developing diabetes. Nat. Med., 2011, 17 (4), 448-453.
33. Viant, M. R. Metabolomics of aquatic organisms: the new 'omics' on the block. Mar. Ecol. Prog. Ser., 2007, 332, 301-306.
34. Bundy, J. G.; Davey, M. P.; Viant, M. R. Environmental metabolomics: a critical review and future perspectives. Metabolomics, 2008, 5 (1), 3-21.
35. Vinayavekhin, N.; Homan, E. A.; Saghatelian, A. Exploring disease through metabolomics. ACS Chem. Biol., 2010, 5 (1), 91-103.
36. Gowda, G. A.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn., 2008, 8 (5), 617-633.
37. Gu, H.; Chen, H.; Pan, Z.; Jackson, A. U.; Talaty, N.; Xi, B.; Kissinger, C.; Duda, C.; Mann, D.; Raftery, D.; Cooks, R. G. Monitoring diet effects via biofluids and their implications for metabolomics studies. Anal. Chem., 2007, 79, 89-97.
38. Olszewski, K. L.; Morrisey, J. M.; Wilinski, D.; Burns, J. M.; Vaidya, A. B.; Rabinowitz, J. D.; Llinas, M. Host-parasite interactions revealed by Plasmodium falciparum metabolomics. Cell Host Microbe, 2009, 5, 191-199.
39. Drexler, D. M.; Reily, M. D.; Shipkova, P. A. Advances in mass spectrometry applied to pharmaceutical metabolomics. Anal. Bioanal. Chem., 2011, 399, 2645-2653.
40. Birungi, G.; Meijie Chen, S.; Pheng Loy, B.; Lee Ng, M.; Fong Yau Li, S. Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line. J. Proteome Res., 2010, 9, 6523-6534.
41. Krishnan, P. Metabolite fingerprinting and profiling in plants using NMR. J. Exp. Bot., 2004, 56 (410), 255-265.
42. Atherton, H. J.; Bailey, N. J.; Zhang, W.; Taylor, J.; Major, H.; Shockcor, J.; Clarke, K.; Griffin, J. L. A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR- null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol. Genomics, 2006, 27 (2), 178-186.
43. Pan, Z.; Raftery, D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal. Bioanal. Chem., 2007, 387 (2), 525-527.
44. Zheng, S.; Zhang, S.; Yu, M.; Tang, J.; Lu, X.; Wang, F.; Yang, J.; Li, F. An 1H NMR and UPLC-MS-based plasma metabonomic study to investigate the biochemical changes in chronic unpredictable mild stress model of depression. Metabolomics, 2011, 7 (3), 413-423.
45. Lanza, I. R.; Zhang, S.; Ward, L. E.; Karakelides, H.; Raftery, D.; Nair, K. S. Quantitative metabolomics by 1H-NMR and LCMS/ MS confirms altered metabolic pathways in diabetes. PLoS One, 2010, 5 (5), e10538.
46. Gu, H.; Pan, Z.; Xi, B.; Asiago, V.; Musselman, B.; Raftery, D. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: Application to the detection of breast cancer. Anal. Chim. Acta, 2011, 686 (1-2), 57-63.
47. Nicholson, J. K.; Buckingham, M. J.; Saldler, P. J. High resolution 1H n.m.r. studies of vertebrate blood and plasma. Biochem. J., 1983, 211 (3), 605-615.
48. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics in pharmaceutical R & D. FEBS J., 2007, 274 (5), 1140-1151.
49. Shin, J.-H.; Yang, J.-Y.; Jeon, B.-Y.; Yoon, Y. J.; Cho, S.-N.; Kang, Y.-H.; Ryu, D. H.; Hwang, G.-S. 1H NMR-based metabolomic profiling in mice infected with mycobacterium tuberculosis. J. Proteome Res., 2011, 10 (5), 2238-2247.
50. Teng, R.; Junankar, P. R.; Bubb, W. A.; Rae, C.; Mercier, P.; Kirk, K. Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by 1H NMR spectroscopy. NMR Biomed., 2009, 22 (3), 292-302.
51. Slupsky, C. M. NMR-based analysis of metabolites in urine provides rapid diagnosis and etiology of pneumonia. Biomarkers Med., 2010, 4 (2), 195-197.
52. DeFeo, E. M.; Wu, C.-L.; McDougal, W. S.; Cheng, L. L. A decade in prostate cancer: from NMR to metabolomics. Nat. Rev. Urol., 2011, 8 (6), 301-311.
53. Ahmed, S. S. S. J.; Santosh, W.; Kumar, S.; Christlet, H. Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J. Biomed. Sci., 2009, 16, 63.
54. Sinclair, A. J.; Viant, M. R.; Ball, A. K.; Burdon, M. A.; Walker, E. A.; Stewart, P. M.; Rauz, S.; Young, S. P. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? NMR Biomed., 2009, 23 (2), 123-132.
55. Beger, R. D.; Schnackenberg, L. K.; Holland, R. D.; Li, D.; Dragan, Y. Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics, 2006, 2 (3), 125-134.
56. Bathe, O. F.; Shaykhutdinov, R.; Kopciuk, K.; Weljie, A. M.; McKay, A.; Sutherland, F. R.; Dixon, E.; Dunse, N.; Sotiropoulos, D.; Vogel, H. J. Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidem. Biomar., 2010, 20 (1), 140-147.
57. Uversky, V. N.; Blasco, H.; Corcia, P.; Moreau, C.; Veau, S.; Fournier, C.; Vourc'h, P.; Emond, P.; Gordon, P.; Pradat, P.-F.; Praline, J.; Devos, D.; Nadal-Desbarats, L.; Andres, C. R. 1HNMR- based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One, 2010, 5 (10), e13223.
58. Bharti, S. K.; Jaiswal, V.; Ghoshal, U.; Ghoshal, U. C.; Baijal, S. S.; Roy, R.; Khetrapal, C. L. Metabolomic profiling of amoebic and pyogenic liver abscesses: an in vitro NMR study. Metabolomics, 2011, Published online.
59. Ramadan, Z.; Jacobs, D.; Grigorov, M.; Kochhar, S. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta, 2006, 68 (5), 1683-1691.
60. Monleón, D.; Morales, J. M.; Barrasa, A.; López, J. A.; Vázquez, C.; Celda, B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed., 2009, 22 (3), 342-348.
61. Auray-Blais, C.; Raiche, E.; Gagnon, R.; Berthiaume, M.; Pasquier, J.-C. Metabolomics and preterm birth: What biomarkers in cervicovaginal secretions are predictive of high-risk pregnant women? International J. Mass Spectrom., 2011, 307 (1-3), 33-38.
62. Beckonert, O.; Keun, H. C.; Ebbels, T. M. D.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2007, 2 (11), 2692-2703.
63. Beckonert, O.; Coen, M.; Keun, H. C.; Wang, Y.; Ebbels, T. M. D.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. High-resolution magicangle- spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat. Protoc., 2010, 5 (6), 1019-1032.
64. Somashekar, B. S.; Kamarajan, P.; Danciu, T.; Kapila, Y. L.; Chinnaiyan, A. M.; Rajendiran, T. M.; Ramamoorthy, A. Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J. Proteome Res., 2011, 10 (11), 5232-5241.
65. Chan, E. C. Y.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res., 2009, 8 (1), 352-361.
66. Wilson, M.; Davies, N. P.; Brundler, M.-A.; McConville, C.; Grundy, R. G.; Peet, A. C. High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours. Mol. Cancer, 2009, 8, 6.
67. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: A Review. Clin. Cancer Res., 2009, 15, 431-440.
68. Saude, E. J.; Sykes, B. D. Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics, 2007, 3 (1), 19-27.
69. Anthony D. Maher, A.D.; Zirah, S.F.M.; Holmes, E.; Nicholsen J.K. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal. Chem., 2007, 79 (14), 5204-5211.
70. Slupsky, C. M.; Rankin, K. N.; Wagner, J.; Fu, H.; Chang, D.; Weljie, A. M.; Saude, E. J.; Lix, B.; Adamko, D. J.; Shah, S.; Greiner, R.; Sykes, B. D.; Marrie, T. J. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem., 2007, 79 (18), 6995-7004.
71. Minami, Y.; Kasukawa, T.; Kakazu, Y.; Iigo, M.; Sugimoto, M.; Ikeda, S.; Yasui, A.; van, d. H. G. T. J.; Soga, T.; Ueda, H. R. Measurement of internal body time by blood metabolomics. Proc. Natl. Acad. Sci. USA, 2009, 106 (24), 9890-9895.
72. Saude, E. J.; Adamko, D.; Rowe, B. H.; Marrie, T.; Sykes, B. D. Variation of metabolites in normal human urine. Metabolomics, 2007, 3 (4), 439-451.
73. NCCLS, Urinalysis and Collection, Transportation, and Preservation of Urine Specimens; Approved Guideline-Second Edition. NCCLS document GP16-A2 [ISBN 1-56238-448-1], NCCLS, 940 West Valley Rd, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2001.
74. Lauridsen, M.; Hansen, S. H.; Jroszewski, J. W.; Cornett, C. Human urine as test material in 1H NMR-based metabonomics: Recommendations for sample preparation and storage. Anal. Chem., 2007, 79 (3), 1181-1186.
75. Winning, H.; Roldán-Marín, E.; Dragsted, L. O.; Viereck, N.; Poulsen, M.; Sánchez-Moreno, C.; Cano, M. P.; Engelsen, S. B. An exploratory NMR nutri-metabonomic investigation reveals dimethyl sulfone as a dietary biomarker for onion intake. The Analyst, 2009, 134 (11), 2344-2351.
76. Winnike, J. H.; Busby, M. G.; Watkins, P. B.; O'Connell, T. M. Effects of a prolonged standardized diet on normalizing the human metabolome. Am. J. Clin. Nutr., 2009, 90 (6), 1496-1501.
77. Bando, K.; Kawahara, R.; Kunimatsu, T.; Sakai, J.; Kimura, J.; Funabashi, H.; Seki, T.; Bamba, T.; Fukusaki, E. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. J. Biosci. Bioeng., 2010, 110 (4), 491-499.
78. Briscoe, C. J.; Hage, D. S. Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis, 2009, 1 (1), 205-220.
79. Canelas, A. B.; Ras, C.; ten Pierick, A.; van Dam, J. C.; Heijnen, J. J.; van Gulik, W. M. Leakage-free rapid quenching technique for yeast metabolomics. Metabolomics, 2008, 4 (3), 226-239.
80. Bernini, P.; Bertini, I.; Luchinat, C.; Nincheri, P.; Staderini, S.; Turano, P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR, 2011, 49 (3-4), 231-243.
81. Rasmussen, L. G.; Savorani, F.; Larsen, T. M.; Dragsted, L. O.; Astrup, A.; Engelsen, S. B. Standardization of factors that influence human urine metabolomics. Metabolomics, 2011, 7 (1), 71-83.
82. Van, C. E.; Shapiro, E. T.; Tillil, H.; Polonsky, K. S. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am. J. Physiol., 1992, 262 (4, Pt. 1), E467- E475.
83. Alum, M. F.; Shaw, P. A.; Sweatman, B. C.; Ubhi, B. K.; Haselden, J. N.; Connor, S. C. 4,4-Dimethyl-4-silapentane-1- ammonium trifluoroacetate (DSA), a promising universal internal standard for NMR-based metabolic profiling studies of biofluids, including blood plasma and serum. Metabolomics, 2008, 4, (2)
84. Bone, I. The increasing importance of inflammation in neurological disease. Curr. Opin. Neurol., 2007, 20, (3), 331-333.
85. Bales, J. R.; P. Higham, D.; Howe, I.; Nicholson, J. K.; Sadler, P. J. Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin. Chem., 1984, 30 (3), 426-432.
86. Jukarainen, N. M.; Korhonen, S.-P.; Laakso, M. P.; Korolainen, M. A.; Niemitz, M.; Soininen, P. P.; Tuppurainen, K.; Vepsäläinen, J.; Pirttilä, T.; Laatikainen, R. Quantification of 1H NMR spectra of human cerebrospinal fluid: a protocol based on constrained totalline- shape analysis. Metabolomics, 2008, 4 (2), 150-160.
87. Amathieu, R.; Nahon, P.; Triba, M.; Bouchemal, N.; Trinchet, J.- C.; Beaugrand, M.; Dhonneur, G.; Le Moyec, L. Metabolomic approach by1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis. J. Proteome Res., 2011, 10 (7), 3239-3245.
88. Wang, J.; Zhang, S.; Li, Z.; Yang, J.; Huang, C.; Liang, R.; Liu, Z.; Zhou, R. 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis. Tumor Biol., 2010, 32 (1), 223-231.
89. Kang, S.-M.; Park, J.-C.; Shin, M.-J.; Lee, H.; Oh, J.; Ryu, D. H.; Hwang, G.-S.; Chung, J. H. 1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin. Biochem., 2011, 44 (4), 293-299.
90. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the madison metabolomics consortium database. Nat. Biotechnol., 2008, 26, (2), 162-164.
91. Ulrich, E. L.; Akutsu, H.; Doreleijers, J. F.; Harano, Y.; Ioannidis, Y. E.; Lin, J.; Livny, M.; Mading, S.; Maziuk, D.; Miller, Z.; Nakatani, E.; Schulte, C. F.; Tolmie, D. E.; Kent Wenger, R.; Yao, H.; Markley, J. L. BioMagResBank. Nucleic Acids Res., 2008, 36, (Database issue), D402-408.
92. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; Macinnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the human metabolome database. Nucleic Acids Res., 2007, 35, (Database issue), D521-526.
93. Forsythe, I. J.; Wishart, D. S. Exploring human metabolites using the human metabolome database. Curr. Protoc. Bioinformatics, 2009, Chapter 14, Unit 14.8.
94. Bertram, H. C.; Malmendal, A.; Petersen, B. O.; Madsen, J. C.; Pedersen, H.; Nielsen, N. C.; Hoppe, C.; Molgaard, C.; Michaelsen, K. F.; Duus, J. O. Effect of magnetic field strength on NMR-based metabonomic human urine data. comparative study of 250, 400, 500, and 800 MHz. Anal. Chem., 2007, 79 (18), 7110-7115.
95. He, Q.; Ren, P.; Kong, X.; Wu, Y.; Wu, G.; Li, P.; Hao, F.; Tang, H.; Blachier, F.; Yin, Y. Comparison of serum metabolite compositions between obese and lean growing pigs using an NMRbased metabonomic approach. J. Nutr. Biochemistry, 2011, 23 (2), 133-139.
96. Rastrelli, F.; Jha, S.; Mancin, F. Seeing through macromolecules: T2-filtered NMR for the purity assay of functionalized nanosystems and the screening of biofluids. J. Am. Chem. Soc., 2009, 131, 14222-14224.
97. Diaz, S. l. O.; Pinto, J.; Graça, G. a.; Duarte, I. F.; Barros, A. n. S.; Galhano, E. l.; Pita, C.; Almeida, M. D. C. U.; Goodfellow, B. J.; Carreira, I. M.; Gil, A. M. Metabolic biomarkers of prenatal disorders: An exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J. Proteome Res., 2011, 10 (8), 3732-3742.
98. Lewis, I. A.; Schommer, S. C.; Hodis, B.; Robb, K. A.; Tonelli, M.; Westler, W. M.; Sussman, M. R.; Markley, J. L. Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Anal. Chem., 2007, 79, 9385-9390.
99. Jeannerat, D.; Furrer, J. NMR experiments for the analysis of mixtures: Beyond 1D 1H spectra. Comb. Chem. High Throughput Screen., 2012, 15 (1), 15-35.
100. Zhang, F.; Bruschweiler-Li, L.; Robinette, S. L. Self-consistent metabolic mixture analysis by heteronuclear NMR. application to a human cancer cell line. Anal. Chem., 2008, 80 (19), 7549-7553.
101. Fan, T. W. M.; Lane, A. N.; Higashi, R. M.; Farag, M. A.; Gao, H.; Bousamra, M.; Miller, D. M. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotoperesolved metabolomics (SIRM). Mol. Cancer, 2009, 8, 41.
102. Moseley, H. N. B.; Lane, A. N.; Belshoff, A. C.; Higashi, R. M.; Fan, T. W. M. A novel deconvolution method for modeling UDPN- acetyl-D-glucosamine biosynthetic pathways based on 13C mass isotopologue profiles under non-steady-state conditions. BMC Biology, 2011, 9 (1), 37.
103. Heikkinen, S.; Toikka, M. M.; Karhunen, P. T.; Kilpeläinen, I. A. Quantitative 2D HSQC (Q-HSQC) via suppression of Jdependence of polarization transfer in NMR spectroscopy: Application to wood lignin. J. Am. Chem. Soc., 2003, 125 (14), 4362-4367.
104. Henderson, T. J. Sensitivity-enhanced quantitative 13C NMR spectroscopy via cancellation of 1JCH dependence in DEPT polarization transfers. J. Am. Chem. Soc., 2004, 126, 3682-3683.
105. Koskela, H.; Kilpeläinen, I.; Heikkinen, S. Some aspects of quantitative 2D NMR. J. Magn. Reson., 2005, 174 (2), 237-244.
106. Gronwald, W.; Klein, M. S.; Kaspar, H.; Fagerer, S. R.; Nürnberger, N.; Dettmer, K.; Bertsch, T.; Oefner, P. J. Urinary metabolite quantification employing 2D NMR spectroscopy. Anal. Chem., 2007, 80, 9288-9297.
107. Hu, F.; Furihata, K.; Kato, Y.; Tanokura, M. Nondestructive quantification of organic compounds in whole milk without pretreatment by two-dimensional NMR spectroscopy. J. Agric. Food Chem., 2007, 55, 4307-4311.
108. Koskela, H.; Heikkilä, O.; Kilpeläinen, I.; Heikkinen, S. Quantitative two-dimensional HSQC experiment for high magnetic field NMR spectrometers. J. Magn. Reson., 2010, 202 (1), 24-33.
109. Hu, K.; Westler, W. M.; Markley, J. L. Simultaneous quantification and identification of individual chemicals in metabolite mixtures by two-dimensional extrapolated time-zero1H-13C HSQC (HSQC0). J. Amer. Chem. Soc., 2011, 133 (6), 1662-1665.
110. Lindon, J. C.; Nicholson, J. K. Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery. TrAC Trends in Anal. Chem., 2008, 27 (3), 194-204.
111. Parsons, H. M.; Ludwig, C.; Günther, U. L.; Viant, M. R. Improved classification accuracy in 1- and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation. BMC Bioinformatics, 2007, 8, 234.
112. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. Nucl. Magn. Reson. Spectrosc., 2001, 39 (1), 1-40.
113. Bylesjoe, M.; Rantalainen, M.; Cloarec, O.; Nicholson, J. K.; Holmes, E.; Trygg, J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemom., 2007, 20, 341-351.
114. Holmes, E.; Nicholson, J. K.; Nicholls, A. W.; Lindon, J. C.; Connor, S. C.; Polley, S.; Connelly, J. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemom. Intell. Lab. Syst., 1998, 44, 245-255.
115. De Meyer, T.; Sinnaeve, D.; Van Gasse, B.; Tsiporkova, E.; Rietzschel, E. R.; De Buyzere, M. L.; Gillebert, T. C.; Bekaert, S.; Martins, J. C.; Criekinge, W. V. NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal. Chem., 2008, 80, 3783-3790.
116. Craig, A.; Cloarec, O.; Holmes, E.; Nicholson, J. K.; Lindon, J. C. Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal. Chem., 2006, 78, 2262-2267.
117. Halouska, S.; Powers, R. Negative impact of noise on the principal component analysis of NMR data. J. Magn. Reson., 2006, 178 (1)
118. Triba, M. N.; Starzec, A.; Bouchemal, N.; Guenin, E.; Perret, G. Y.; Le Moyec, L. Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells. NMR Biomed., 2010, 23 (9), 1009-1016.
119. van den Berg, R. A.; Hoefsloot, H. C. J.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics, 2006, 7, 142.
120. Zhang, B.; Halouska, S.; Schiaffo, C. E.; Sadykov, M. R.; Somerville, G. A.; Powers, R. NMR analysis of a stress response metabolic signaling network. J. Proteome Res., 2011, 10, 3743-3754.
121. Westerhuis, J. A.; Velzen, E. J. J.; Hoefsloot, H. C. J.; Smilde, A. K. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics, 2009, 6 (1), 119-128.
122. Molteni, C. G.; Cazzaniga, G.; Condorelli, D. F.; Fortuna, C. G.; Biondi, A.; Musumarra, G. Successful application of OPLS-DA for the discrimination of wild-type and mutated cells in acute lymphoblastic leukemia. QSAR Comb. Sci., 2009, 28 (8), 822-828.
123. Basant, A.; Rege, M.; Sharma, S.; Sonawat, H. M. Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression. Malaria J., 2010, 9, 110.
124. Westerhuis, J. A.; Hoefsloot, H. C. J.; Smit, S.; Vis, D. J.; Smilde, A. K.; van Velzen, E. J. J.; van Duijnhoven, J. P. M.; van Dorsten, F. A. Assessment of PLSDA cross validation. Metabolomics, 2008, 4, 81-89.
125. Efron, B.; Halloran, E.; Holmes, S. Bootstrap confidence levels for phylogenetic trees. Proc. Natl. Acad. Sci. U S A, 1996, 93 (23), 13429-13434.
126. Werth, M. T.; Halouska, S.; Shortridge, M. D.; Zhang, B.; Powers, R. Analysis of metabolomic PCA data using tree diagrams. Anal. Biochem., 2010, 399 (1), 58-63.
127. Retief, J. D. Phylogenetic analysis using PHYLIP. Methods Mol. Biol., 2000, 132, 243-258.
128. Zhang, B.; Halouska, S.; Schiaffo, C. E.; Sadykov, M. R.; Somerville, G. A.; Powers, R. NMR analysis of a stress response metabolic signaling network. J. Proteome Res., 2011, 10 (8), 3743-3754.
129. Halouska, S.; Fenton, R. J.; Barletta, R. l. G.; Powers, R. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem. Biol., 2012, 7 (1), 166-171.
130. Carrola, J.; Rocha, C. M.; Barros, A. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J.; Gomes, A.; Sousa, V.; Carvalho, L.; Duarte, I. F. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res, 2011, 10 (1), 221-230.
131. Chiaradonna, F.; Moresco, R. M.; Airoldi, C.; Gaglio, D.; Palorini, R.; Nicotra, F.; Messa, C.; Alberghina, L. From cancer metabolism to new biomarkers and drug targets. Biotechnol. Adv., 2012, 30 (1), 30-51.
132. MacKinnon, N.; Khan, A. P.; Chinnaiyan, A. M.; Rajendiran, T. M.; Ramamoorthy, A. Androgen receptor activation results in metabolite signatures of an aggressive prostate cancer phenotype: an NMR-based metabonomics study. Metabolomics, 2012, published online.
133. Bernini, P.; Bertini, I.; Luchinat, C.; Tenori, L.; Tognaccini, A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples. J. Proteome Res., 2011, 10 (11), 4983-4992.
134. Heinzmann, S. S.; Brown, I. J.; Chan, Q.; Bictash, M.; Dumas, M. E.; Kochhar, S.; Stamler, J.; Holmes, E.; Elliott, P.; Nicholson, J. K. Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption. Am. J. Clin. Nutr., 2010, 92 (2), 436-443.